Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials.
Saved in:
| Title: | Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials. |
|---|---|
| Authors: | Saj F; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Namayanja FK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borad MJ; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA., Kelley RK; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, USA., Goyal L; Department of Medicine, Division of Hematology and Oncology, Stanford Cancer Center, Palo Alto, California, USA., Azad NS; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bachini M; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Lindsey S; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Valle JW; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Fashoyin-Aje LA; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Javle M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | Cancer [Cancer] 2026 Jan 01; Vol. 132 (1), pp. e70227. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41417596 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Saj+F%22">Saj F</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Namayanja+FK%22">Namayanja FK</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Xiao+L%22">Xiao L</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Borad+MJ%22">Borad MJ</searchLink>; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Kelley+RK%22">Kelley RK</searchLink>; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Goyal+L%22">Goyal L</searchLink>; Department of Medicine, Division of Hematology and Oncology, Stanford Cancer Center, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Azad+NS%22">Azad NS</searchLink>; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bachini+M%22">Bachini M</searchLink>; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Lindsey+S%22">Lindsey S</searchLink>; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Pant+S%22">Pant S</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Valle+JW%22">Valle JW</searchLink>; The Cholangiocarcinoma Foundation, Herriman, Utah, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Fashoyin-Aje+LA%22">Fashoyin-Aje LA</searchLink>; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Javle+M%22">Javle M</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2026 Jan 01; Vol. 132 (1), pp. e70227. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41417596 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.70227 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70227 Titles: – TitleFull: Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Saj F – PersonEntity: Name: NameFull: Namayanja FK – PersonEntity: Name: NameFull: Xiao L – PersonEntity: Name: NameFull: Borad MJ – PersonEntity: Name: NameFull: Kelley RK – PersonEntity: Name: NameFull: Goyal L – PersonEntity: Name: NameFull: Azad NS – PersonEntity: Name: NameFull: Bachini M – PersonEntity: Name: NameFull: Lindsey S – PersonEntity: Name: NameFull: Pant S – PersonEntity: Name: NameFull: Valle JW – PersonEntity: Name: NameFull: Fashoyin-Aje LA – PersonEntity: Name: NameFull: Javle M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1097-0142 Numbering: – Type: volume Value: 132 – Type: issue Value: 1 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |